3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Keratosis, Actinic
2
Pituitary Neoplasms
1
Pain
1
Neoplasms
1
Metastatic Castration-resistant Prostate Cancer (mCRPC)
1
Lung Neoplasms
1
Hemorrhage
1
Haloperidol
1
Growth Hormone-Secreting Pituitary Adenoma
1
Brain Neoplasms
1
Anemia
1
Acromegaly
1
Interventions
pasireotide
2
Cabergoline
2
lanreotide
1
Solutions
1
Radiosurgery
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Pituitary Neoplasms
×
Solutions
×
Clear all
NCT03439709
2018-03-01
MERGE
Samsung Medical Center
Phase 3
Unknown
90 enrolled